ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 40 filers reported holding ALEXZA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.04 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $374,000 | -31.4% | 771,753 | -0.8% | 0.00% | -100.0% |
| Q4 2015 | $545,000 | -43.5% | 778,097 | -0.7% | 0.00% | 0.0% |
| Q3 2015 | $964,000 | +12.7% | 783,342 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $855,000 | -47.6% | 783,865 | -0.6% | 0.00% | -50.0% |
| Q1 2015 | $1,633,000 | +38.6% | 788,638 | -0.2% | 0.00% | +100.0% |
| Q4 2014 | $1,178,000 | -35.9% | 790,143 | +0.2% | 0.00% | 0.0% |
| Q3 2014 | $1,838,000 | -49.1% | 788,880 | -0.2% | 0.00% | -66.7% |
| Q2 2014 | $3,612,000 | +3.1% | 790,355 | -0.0% | 0.00% | 0.0% |
| Q1 2014 | $3,503,000 | -5.1% | 790,647 | +1.3% | 0.00% | 0.0% |
| Q4 2013 | $3,693,000 | -7.6% | 780,816 | -0.0% | 0.00% | -25.0% |
| Q3 2013 | $3,998,000 | +40.8% | 781,007 | +19.4% | 0.00% | +33.3% |
| Q2 2013 | $2,839,000 | -15.6% | 654,292 | -14.1% | 0.00% | 0.0% |
| Q1 2013 | $3,365,000 | – | 761,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,355,255 | $6,410,000 | 100.00% |
| FORTALEZA ASSET MANAGEMENT INC/ | 142,180 | $673,000 | 0.34% |
| Lombard Odier & Cie (Bahamas) Ltd | 44,000 | $208,000 | 0.08% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $468,000 | 0.07% |
| KENNEDY CAPITAL MANAGEMENT LLC | 476,645 | $2,255,000 | 0.04% |
| BBT Capital Management, LLC | 118,033 | $558,000 | 0.02% |
| ROCKY MOUNTAIN ADVISERS, LLC | 350 | $2,000 | 0.02% |
| Jefferies Group LLC | 520,400 | $2,461,000 | 0.02% |
| Granite Point Capital Management, L.P. | 16,574 | $78,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 55,000 | $260,000 | 0.01% |